John Hogan sadly passed away on January 3, 2021, as a result of complications from the COVID-19 virus in a hospital near his home in Verbier, Switzerland.

PMI has co-sponsored a paper led by Cornell University professor Dr. Karan Girotra on the crucial role transformation plays in ensuring businesses prosper in a world demanding sustainable solutions.

Following the former CEO’s retirement from his position as Chairman of the Board, we celebrate his 40 illustrious years at PMI.

The U.S. Food and Drug Administration grants premarket tobacco product application orders to an updated version of our electronically heated tobacco system.

Read Philip Morris International's White Paper Winter 20/21.

PMI CEO André Calantzopoulos has signed up to The Valuable 500 to accelerate our action to advancing disability inclusion across our global workforce.

Philip Morris International has been recognized as one of the world's most pioneering companies leading on environmental transparency and performance.

The global scheme will launch as of January 1, 2021, and strengthens the company’s commitment to fostering a more inclusive and diverse workforce.

Philip Morris International’s efforts to combat fraudsters in the wake of COVID-19 have also yielded three coveted accolades at the 2020 MarCom Awards.

PM Equity Partner is funding ideas and collaborating with startups to deliver a smoke-free future.

Information about the U.S. Food and Drug Administration’s (FDA’s) assessment of PMI's extensive scientific evidence package, and its July 7, 2020, decision to authorize IQOS as a modified risk tobacco product with reduced exposure information.

The biopharmaceutical company has reached an agreement with two departments of the Canadian government to accelerate its COVID-19 vaccine candidate efforts.

Read the full transcript of Philip Morris International CEO André Calantzopoulos’ virtual Concordia speech on the importance of science to drive progress.